9.1(top 2%)
impact factor
9.2K(top 2%)
papers
351.4K(top 1%)
citations
216(top 1%)
h-index
9.5(top 2%)
impact factor
10.8K
all documents
368.6K
doc citations
352(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis20066,039
2Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis20204,615
3Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patientsJournal of Thrombosis and Haemostasis20053,778
4Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis20202,925
5Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patientsJournal of Thrombosis and Haemostasis20101,826
6ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis20201,513
7Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis20201,482
8Fibrinogen and fibrin structure and functionsJournal of Thrombosis and Haemostasis20051,382
9Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapyJournal of Thrombosis and Haemostasis20071,309
10Incidence of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis20201,227
11Incidence and mortality of venous thrombosis: a population-based studyJournal of Thrombosis and Haemostasis20071,134
12Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasisJournal of Thrombosis and Haemostasis20201,070
13Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand FactorJournal of Thrombosis and Haemostasis20061,061
14Update of the guidelines for lupus anticoagulant detectionJournal of Thrombosis and Haemostasis20091,055
15D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19Journal of Thrombosis and Haemostasis2020986
16High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patientsJournal of Thrombosis and Haemostasis2020984
17Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trialJournal of Thrombosis and Haemostasis2007942
18Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settingsJournal of Thrombosis and Haemostasis2006916
19Protease-activated receptors in hemostasis, thrombosis and vascular biologyJournal of Thrombosis and Haemostasis2005909
20Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis2015889
21A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction ScoreJournal of Thrombosis and Haemostasis2010864
22Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis2010813
23The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndromeJournal of Thrombosis and Haemostasis2020791
24Neutrophil extracellular traps promote deep vein thrombosis in miceJournal of Thrombosis and Haemostasis2012741
25Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensingJournal of Thrombosis and Haemostasis2014698
26Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrelJournal of Thrombosis and Haemostasis2007668
27The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhageJournal of Thrombosis and Haemostasis2007627
28Thrombopoietin: a tool for understanding thrombopoiesisJournal of Thrombosis and Haemostasis2003622
29ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disordersJournal of Thrombosis and Haemostasis2010607
30Multiple roles of the endothelial cell protein C receptorJournal of Thrombosis and Haemostasis2007589
31Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentrationJournal of Thrombosis and Haemostasis2014577
32Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage studyJournal of Thrombosis and Haemostasis2006568
33Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA studyJournal of Thrombosis and Haemostasis2008560
34In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939-an oral, direct Factor Xa inhibitorJournal of Thrombosis and Haemostasis2005558
35Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis2020547
36Fibrin structure and wound healingJournal of Thrombosis and Haemostasis2006546
37The platelet contribution to cancer progressionJournal of Thrombosis and Haemostasis2011545
38A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)1Journal of Thrombosis and Haemostasis2005534
39Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trialJournal of Thrombosis and Haemostasis2007534
40Definitions in hemophilia: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis2014530
41Thromboinflammation and the hypercoagulability of COVID‐19Journal of Thrombosis and Haemostasis2020529
42Clinical course of high‐risk patients diagnosed with antiphospholipid syndromeJournal of Thrombosis and Haemostasis2010527
43Microparticle-associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis2007506
44What is all that thrombin for?Journal of Thrombosis and Haemostasis2003480
45A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)Journal of Thrombosis and Haemostasis2006478
46Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomesJournal of Thrombosis and Haemostasis2012473
47International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerJournal of Thrombosis and Haemostasis2013469
48Platelet functions beyond hemostasisJournal of Thrombosis and Haemostasis2009465
49Pathological evidence of pulmonary thrombotic phenomena in severe COVID‐19Journal of Thrombosis and Haemostasis2020461
50Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case seriesJournal of Thrombosis and Haemostasis2020456